Professor T. Hugh Jones

BSc(Hons), MBChB, MD, FRCP(London), FRCP(Edinburgh)

School of Medicine and Population Health

Honorary Professor of Andrology

Consultant Physician in Diabetes and Endocrinology, Barnsley Hospital NHS Trust, Barnsley.

Hon. Consultant Endocrinologist, Endocrinology, Royal Hallamshire Hospital, Sheffield

Professor Thomas Hugh Jones
Professor Thomas Hugh Jones
Profile picture of Professor Thomas Hugh Jones
t.h.jones@sheffield.ac.uk
+44 1226 431 684 (NHS Secretary)
The Medical School

Full contact details

Professor T. Hugh Jones
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

Hugh Jones is a world-leader researching the role of testosterone deficiency in the pathogenesis of Heart disease and Diabetes and the therapeutic benefits of testosterone replacement therapy in these conditions. He is a member of national and international guideline committees for the diagnosis and treatment of Male Testosterone Deficiency.

He studied Biochemistry BSc(Hons) (1972-1975) and then Medicine (1975-1980) at Sheffield University. I then trained as a junior doctor in Sheffield and Barnsley attaining MRCP(UK) 1984. This was followed by Clinical Research Fellow in the Department of Human Metabolism and Biochemistry (1985-1988) and then was appointing as Lecturer in Medicine both at University of Sheffield (1988-1993).As Consultant Physician with special interest in Diabetes and Endocrinology firstly in the Royal Hallamshire Hospital 1984-1998 and then Barnsley Hospital (1998 to present).

He has led clinical and laboratory teams which have made important contributions which include being first to demonstrate that testosterone reduces Insulin Resistance, improves glycaemic control (HbA1c) and quality of life in men with type 2 diabetes with hypogonadism. He identified that 40% of men with Type 2 Diabetes have symptomatic testosterone deficiency (male hypogonadism). 

Professor Jones is one of the founder members of the international Androgen Society formed in 2017. He has been on the Guideline committees for Testosterone Deficiency and it s management for the European Association of Urology, British Society for Sexual Medicine and the International Consensus of Sexual Medicine. He has also been Chair of the Academic sub-committee for the Association of British Clinical Diabetologists, Chair Of Specialist Education Committee for spR training in Diabetes and Endocrinology for the Three Deaneries-Leicester, Nottingham and South Yorkshire, Training Programme Director for spR’s in Diabetes and Endocrinology in South Yorkshire.

Publications

Books

  • Jones T (2013) Testosterone Deficiency in Men.
  • Nieschlag E, Behre HM & Nieschlag S (2012) Testosterone Action, Deficiency, Substitution. Cambridge University Press.
  • Jones TH & Guaraldi F (2008) Advances in the Management of Testosterone Deficiency. Karger Medical and Scientific Publishers.
  • Jones H (2008) Testosterone Deficiency in Men. Oxford University Press, USA.

Journal articles

  • Kelly DM, Mirecka M, Jones TH, Ingle L & Nichols S (2025) . Journal of the Endocrine Society, 9(Supplement_1).
  • Morgentaler A, Dhindsa S, Dobs AS, Hackett G, Jones TH, Kloner RA, Miner M, Zitzmann M & Traish AM (2024) . Mayo Clinic Proceedings, 99(11), 1785-1801.
  • Mumdzic E, Rao P & Jones TH (2024) . Journal of the Endocrine Society, 8(Supplement_1).
  • Williamson A, Bateman L, LeMaitre C, Jones TH, Aberdein N & Kelly DM (2024) . Journal of the Endocrine Society, 8(Supplement_1).
  • JONES TH, HAIDER A, SULTAN HAIDER K, CULL ML & RYDER RE (2024) . Diabetes, 73(Supplement_1).
  • Gül M, Luca B, Dimitropoulos K, Capogrosso P, Milenkovic U, Cocci A, Veeratterapillay R, Hatzichristodoulou G, Modgil V, Russo GI , Tharakan T et al (2024) . International Journal of Impotence Research, 36(1), 20-35.
  • Jones TH, Dobs AS, Randeva H, Moore W & Parkin JM (2023) . European Journal of Endocrinology, 189(3), 297-308.
  • Hackett G, Kirby M, Rees RW, Jones TH, Muneer A, Livingston M, Ossei-Gerning N, David J, Foster J, Kalra PA & Ramachandran S (2023) . The World Journal of Men's Health, 41(3), 508-508.
  • Mohan Rao P, Mumdzic E, Kelly DM & Hugh Jones T (2022) . Journal of the Endocrine Society, 6(Supplement_1), A717-A717.
  • Perros P, Basu A, Boelaert K, Dayan C, Vaidya B, Williams GR, Lazarus JH, Hickey J, Drake WM, Crown A , Orme SM et al (2022) . Clinical Endocrinology, 97(5), 664-675.
  • Grossmann M & Jones TH (2021) . European Journal of Endocrinology, 185(3), D1-D9.
  • Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, Cocci A, Corona G, Dimitropoulos K, Gül M , Hatzichristodoulou G et al (2021) . European Urology, 80(3), 333-357.
  • Kilby EL, Kelly DM & Jones TH (2021) . Life Sciences, 269, 119040-119040.
  • Bateman L, Rao P, Jones TH & Kelly DM (2020) . Journal of the Endocrine Society, 4(Supplement_1).
  • Mumdzic E, Rao PM & Jones TH (2020) . Journal of the Endocrine Society, 4(Supplement_1).
  • Rao PM, Mumdzic E, Kelly DM & Jones TH (2020) . Journal of the Endocrine Society, 4(Supplement_1).
  • Bateman L, Dalton C, Maitre CL, Jones TH & Kelly DM (2020) . Journal of the Endocrine Society, 4(Supplement_1).
  • Morgentaler A, Traish A, Hackett G, Jones TH & Ramasamy R (2019) . Sexual Medicine Reviews, 7(4), 636-649.
  • Mumdzic E, Morganti E, Gowda S, Rao P & Jones T (2019) . Journal of the Endocrine Society, 3(Supplement_1).
  • Bateman L, Jones T & Kelly D (2019) . Journal of the Endocrine Society, 3(Supplement_1).
  • Kelly D, Nettleship J & Jones T (2019) . Journal of the Endocrine Society, 3(Supplement_1).
  • Church D, Cardoso L, Kay RG, Williams CL, Freudenthal B, Clarke C, Harris J, Moorthy M, Karra E, Gribble FM , Reimann F et al (2018) . The Journal of Clinical Endocrinology & Metabolism, 103(10), 3845-3855.
  • Arver S, Stief C, de la Rosette J, Jones TH, Neijber A & Carrara D (2018) . Andrology, 6(3), 396-407.
  • Jones TH & Kelly DM (2018) . Asian Journal of Andrology, 20(2), 120-130.
  • Jones T & Kelly D (2018) . Asian Journal of Andrology, 20(2), 120-120.
  • Dimitriadis GK, Randeva HS, Aftab S, Ali A, Hattersley JG, Pandey S, Grammatopoulos DK, Valsamakis G, Mastorakos G, Jones TH & Barber TM (2018) . Endocrine, 60(1), 175-184.
  • Hackett G, Kirby M, Edwards D, Jones TH, Wylie K, Ossei-Gerning N, David J & Muneer A (2017) . Journal of Sexual Medicine, 14(12), 1504-1523.
  • Hackett G, Kirby M, Edwards D, Jones TH, Rees J & Muneer A (2017) . International Journal of Clinical Practice, 71(3-4).
  • Kelly DM, Akhtar S, Sellers DJ, Muraleedharan V, Channer KS & Jones TH (2016) . Endocrine.
  • Gosai JN, Charalampidis P, Nikolaidou T, Parviz Y, Morris PD, Channer KS, Jones TH & Grech ED (2016) . Andrology, 4(3), 486-491.
  • Kelly DM & Jones TH (2015) . Obesity Reviews, 16(7), 581-606.
  • Jones TH (2015) Testosterone and cardiovascular disease. Heart and Metabolism(66), 7-12.
  • Jones TH (2014) . Diabetes Care, 37(12), e267-e268.
  • Zarotsky V, Huang M, Carman W, Morgentaler A, Singhal PK, Coffin D & Jones TH (2014) . Andrology, 2(6), 819-834.
  • Zarotsky V, Huang M-Y, Carman W, Morgentaler A, Singhal PK, Coffin D & Jones TH (2014) . Journal of Hormones, 2014, 1-17.
  • Muraleedharan V & Hugh Jones T (2014) . Clinical Endocrinology, 81(4), 477-487.
  • Kelly DM, Nettleship JE, Akhtar S, Muraleedharan V, Sellers DJ, Brooke JC, McLaren DS, Channer KS & Jones TH (2014) . Life Sciences, 109(2), 95-103.
  • Kelly DM & Jones TH (2014) , 1-20.
  • Jones TH & Channer KS (2014) . JAMA, 311(9), 962-962.
  • Brooke JC, Walter DJ, Kapoor D, Marsh H, Muraleedharan V & Jones TH (2014) . Andrology, 2(2), 205-211.
  • Jones TH (2014) . The Lancet Diabetes & Endocrinology, 2(8), 612-613.
  • Stanworth RD, Akhtar S, Channer KS & Jones TH (2014) . European Journal of Endocrinology, 170(2), 193-200.
  • Muraleedharan V, Marsh H, Kapoor D, Channer KS & Jones TH (2013) . European Journal of Endocrinology, 169(6), 725-733.
  • Rao PM, Kelly DM & Jones TH (2013) . Nature Reviews Endocrinology, 9(8), 479-493.
  • Kelly DM & Jones TH (2013) . Journal of Endocrinology, 217(3), R47-R71.
  • Kelly DM & Jones TH (2013) . Journal of Endocrinology, 217(3), R25-R45.
  • Jones TH, Howell JD & Channer KS (2011) . Diabetes Care, 34(11), e173-e173.
  • Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M & Cunningham G (2011) . Diabetes Care, 34(7), 1669-1675.
  • Stanworth RD, Kapoor D, Channer KS & Jones TH (2011) . Clinical Endocrinology, 74(5), 624-630.
  • Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, Morales AM, Volterrani M, Yellowlees A, Howell JD & Channer KS (2011) . Diabetes Care, 34(4), 828-837.
  • Jones TH, Quinton R & Ullah A (2011) . Practical Diabetes International, 28(1), 14-14.
  • Debono M, Chan S, Rolfe C & Jones TH (2011) . European Journal of Clinical Pharmacology, 67(8), 865-867.
  • Muraleedharan V & Jones TH (2010) . Therapeutic Advances in Endocrinology and Metabolism, 1(5), 207-223.
  • Dhatariya K, Nagi D & Jones TH (2010) . Practical Diabetes International, 27(9), 408-412.
  • Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH & Channer KS (2010) . Heart, 96(22), 1821-1825.
  • Muraleedharan V, Marsh H & Jones TH (2010) . Journal of Men's Health, 7(3), 319-319.
  • JONES TH (2010) . Journal of Diabetes, 2(3), 146-156.
  • Malkin CJ, Channer KS & Jones TH (2010) . Current Opinion in Endocrinology, Diabetes & Obesity, 17(3), 262-268.
  • Jones TH (2010) . Trends in Endocrinology & Metabolism, 21(8), 496-503.
  • Hugh Jones T (2010) . Clinical Endocrinology, 72(5), 584-588.
  • Jones TH (2009) . Journal of Men's Health, 6(4), 398-398.
  • Mathur A, Malkin C, Saeed B, Muthusamy R, Jones TH & Channer K (2009) . European Journal of Endocrinology, 161(4), 653-653.
  • Mathur A, Malkin C, Saeed B, Muthusamy R, Jones TH & Channer K (2009) . European Journal of Endocrinology, 161(3), 443-449.
  • Rowell KO, Hall J, Pugh PJ, Jones TH, Channer KS & Jones RD (2009) . Journal of Endocrinological Investigation, 32(9), 718-723.
  • Jones TH & Saad F (2009) . Atherosclerosis, 207(2), 318-327.
  • Hall J, Jones TH, Channer KS & Jones RD (2009) . Vascular Pharmacology, 51(1), 8-12.
  • Stanworth RD, Kapoor D, Channer KS & Jones TH (2009) . Diabetes Care, 32(4), 541-546.
  • Kapoor D & Jones TH (2008) . Drugs & Aging, 25(5), 357-369.
  • Smith AM, Bennett RT, Jones TH, Cowen ME, Channer KS & Jones RD (2008) Characterization of the vasodilatory action of testosterone in the human pulmonary circulation. Vascular Health and Risk Management, 4(6), 1459-1466.
  • Jones TH (2008) , 1-4.
  • Stanworth RD & Jones TH (2008) , 74-90.
  • Malkin CJ, Jones TH & Channer KS (2008) , 183-196.
  • Nettleship JE, Jones RD, Channer KS & Jones TH (2008) , 91-107.
  • Stanworth RD, Kapoor D, Channer KS & Jones TH (2008) . European Journal of Endocrinology, 159(6), 739-746.
  • Jones TH (2008) . Journal of Men's Health, 5(S), S26-S34.
  • Kapoor D, Channer KS & Jones TH (2008) . Diabetes and Vascular Disease Research, 5(2), 135-137.
  • Nettleship JE, Jones TH, Channer KS & Jones RD (2007) . Circulation, 116(21), 2427-2434.
  • Jones TH (2007) . European Urology Supplements, 6(16), 847-857.
  • Kapoor D, Clarke S, Channer KS & Jones TH (2007) . International Journal of Andrology, 30(6), 500-507.
  • Jones TH (2007) . Practical Diabetes International, 24(5), 269-277.
  • Kapoor D, Clarke S, Stanworth R, Channer KS & Jones TH (2007) . European Journal of Endocrinology, 156(5), 595-602.
  • Nettleship J, Pugh P, Channer K, Jones T & Jones R (2007) . Hormone and Metabolic Research, 39(5), 366-371.
  • Kapoor D, Aldred H, Clark S, Channer KS & Jones TH (2007) . Diabetes Care, 30(4), 911-917.
  • Malkin CJ, Jones TH & Channer KS (2007) . European Journal of Heart Failure, 9(1), 44-50.
  • Jones TH (2007) . British Journal of Hospital Medicine, 68(10), 547-553.
  • Malkin CJ, Jones RD, Jones TH & Channer KS (2006) . Clinical Science, 111(4), 265-274.
  • Kapoor D, Goodwin E, Channer KS & Jones TH (2006) . European Journal of Endocrinology, 154(6), 899-906.
  • Hall J, Jones TH, Channer KS & Jones RD (2006) . Vascular Pharmacology, 44(6), 427-433.
  • Hall J, Jones RD, Jones TH, Channer KS & Peers C (2006) . Endocrinology, 147(6), 2675-2680.
  • Smith AM, Morris P, Rowell KO, Clarke S, Jones TH & Channer KS (2006) . Clinical Medicine, 6(2), 174-177.
  • Malkin CJ, Pugh PJ, West JN, van Beek EJR, Jones TH & Channer KS (2006) . European Heart Journal, 27(1), 57-64.
  • Pugh PJ, Jones RD, Malkin CJ, Hall J, Nettleship JE, Kerry KE, Hugh Jones T & Channer KS (2005) . Endocrine Research, 31(4), 271-283.
  • Kapoor D, Malkin CJ, Channer KS & Jones TH (2005) . Clinical Endocrinology, 63(3), 239-250.
  • Kapoor D & Jones TH (2005) . European Journal of Endocrinology, 152(4), 491-499.
  • Borg SA, Kerry KE, Royds JA, Battersby RD & Jones TH (2005) . European Journal of Endocrinology, 152(2), 293-300.
  • Smith AM, English KM, Malkin CJ, Jones RD, Jones TH & Channer KS (2005) . European Journal of Endocrinology, 152(2), 285-291.
  • Jones RD, Jones TH & Channer KS (2004) . Nature, 432(7016), 439-439.
  • Morris PD, Malkin CJ, Channer KS & Jones TH (2004) . European Journal of Endocrinology, 241-249.
  • JONES RD, ENGLISH KM, JONES TH & CHANNER KS (2004) . Clinical Science, 107(2), 149-158.
  • Malkin CJ (2004) . Heart, 90(8), 871-876.
  • Jones RD, Hugh Jones T & Channer KS (2004) . European Journal of Endocrinology, 29-37.
  • Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS & Jones TH (2004) . The Journal of Clinical Endocrinology & Metabolism, 89(7), 3313-3318.
  • Scragg JL, Jones RD, Channer KS, Jones TH & Peers C (2004) . Biochemical and Biophysical Research Communications, 318(2), 503-506.
  • Pugh PJ (2004) . Heart, 90(4), 446-447.
  • Ross RJ, Jabbar A, Jones TH, Roberts B, Dunkley K, Hall J, Long A, Levine H & Cullen DR (2004) . European Journal of Endocrinology, 57-63.
  • Jones RD, Pugh PJ, Jones TH & Channer KS (2003) . British Journal of Pharmacology, 138(5), 733-744.
  • Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, McNicol AM, Ferrier R, Jones TH, Baldeweg S, Powell M , Czirják S et al (2003) . The Journal of Clinical Endocrinology & Metabolism, 88(12), 6080-6087.
  • Borg SA, Kerry KE, Baxter L, Royds JA & Jones TH (2003) . The Journal of Clinical Endocrinology & Metabolism, 88(10), 4938-4944.
  • Jones RD, Ruban LN, Morton IE, Roberts SA, English KM, Channer KS & Jones TH (2003) . Journal of Endocrinology, 178(3), 381-393.
  • Malkin CJ, Pugh PJ, Jones RD, Jones TH & Channer KS (2003) . Journal of Endocrinology, 178(3), 373-380.
  • Malkin CJ, Pugh PJ, Jones TH & Channer KS (2003) . QJM, 96(7), 521-529.
  • Pugh P (2003) . European Heart Journal, 24(10), 909-915.
  • Jones RD, Malkin CJ, Channer KS & Jones TH (2003) . The Journal of Clinical Endocrinology & Metabolism, 88(3), 1403-1404.
  • Channer KS (2003) . Heart, 89(2), 121-122.
  • Jones RD, Pugh PJ, Hall J, Channer KS & Jones TH (2003) . European Journal of Endocrinology, 111-120.
  • English KM, Jones RD, Jones TH, Morice AH & Channer KS (2002) . Journal of Endocrinological Investigation, 25(5), 455-458.
  • Pugh PJ, Channer KS, Parry H, Downes T & Hugh Jones T (2002) . Endocrine Research, 28(3), 161-173.
  • Pugh PJ, Jones RD, Jones TH & Channer KS (2002) . European Journal of Heart Failure, 4(6), 673-680.
  • Pugh PJ, Jones RD, Jones TH & Channer KS (2002) . Clinical Science, 103(s47), 6P-6P.
  • Jones RD, English KM, Pugh PJ, Morice AH, Jones TH & Channer KS (2002) . Journal of Cardiovascular Pharmacology, 39(6), 814-823.
  • Pugh PJ, Jones RD, Jones TH & Channer KS (2002) . Clinical Science, 102(s46), 5P-6P.
  • Morris PD, Pugh PJ, Jones TH & Channer KS (2002) . Clinical Science, 102(s46), 5P-5P.
  • Korbonits M, Chitnis MM, Gueorguiev M, Norman D, Rosenfelder N, Suliman M, Jones TH, Fabbri KNA, Besser GM, Burrin JM & Grossman AB (2001) . Clinical Endocrinology, 54(6), 781-789.
  • English KM, Jones RD, Jones TH, Morice AH & Channer KS (2001) . Hormone and Metabolic Research, 33(11), 645-652.
  • Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R & Jones TH (2001) . Clinical Endocrinology, 54(3), 317-325.
  • Pugh PJ, Jones RD, Jones TH & Channer KS (2001) . Clinical Science, 101(s45), 4P-4P.
  • ENGLISH KM, PUGH PJ, PARRY H, SCUTT NE, CHANNER KS & JONES TH (2001) . Clinical Science, 100(6), 661-661.
  • English K (2001) . European Heart Journal, 22(7), 613-613.
  • English KM, Steeds RP, Jones TH, Diver MJ & Channer KS (2000) . Circulation, 102(16), 1906-1911.
  • Pugh PJ, English KM, Jones TH & Channer KS (2000) . QJM: An International Journal of Medicine, 93(10), 689-694.
  • ENGLISH KM, JONES RD, JONES TH, MORICE AH & CHANNER KS (2000) . Clinical Science, 99(1), 77-77.
  • English K (2000) . European Heart Journal, 21(11), 890-894.
  • Adeniji AA, Fairlie FM, Jones TH & Wilkinson P (1999) . BJOG: An International Journal of Obstetrics & Gynaecology, 106(12), 1316-1318.
  • Suliman ME, Royds JA, Baxter L, Timperley WR, Cullen DR & Jones TH (1999) . European Journal of Endocrinology, 155-158.
  • Jones TH, Wadler S & Hupart KH (1998) Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha.. Semin Oncol, 25(1 Suppl 1), 54-63.
  • Jones TH, Wadler S & Hupart KH (1998) Endocrine-mediated mechanisms of fatigue during treatment with interferon-α. SEMINARS IN ONCOLOGY, 25(1), 54-63.
  • Jones TH, Justice SK, Timperley WR & Royds JA (1997) . The Journal of Pathology, 183(4), 460-468.
  • English KM, Steeds R, Jones TH & Channer KS (1997) . QJM, 90(12), 787-791.
  • Jones TH, Kennedy RL, Justice SK & Davies R (1997) . European Journal of Endocrinology, 429-432.
  • Jones TH, Justice SK & Price A (1997) . J Clin Endocrinol Metab, 82(7), 2143-2147.
  • Guo C-Y (1997) . Journal of Clinical Endocrinology & Metabolism, 82(2), 658-665.
  • Jones TH (1995) The management of hyperprolactinaemia.. British Journal of Hospital Medicine, 53(8), 374-378.
  • Jones TH, Hunter SM, Price A & Angelini GD (1995) . The Annals of Thoracic Surgery, 59(5), 1274-1275.
  • Jones TH (1994) . Clinical Endocrinology, 40(6), 703-713.
  • Jones TH & Fraser RB (1994) . BJOG: An International Journal of Obstetrics & Gynaecology, 101(4), 349-350.
  • Jones TH, Darne JF & McGarrigle HHG (1994) . European Journal of Endocrinology, 131(2), 173-178.
  • Jones TH, Hunter SM, Price A & Angelini GD (1994) . The Annals of Thoracic Surgery, 58(2), 434-436.
  • Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P & Weetman AP (1994) . The Journal of Clinical Endocrinology & Metabolism, 78(1), 180-187.
  • Jones TH, Kennedy RL, Justice SK & Price A (1993) . Clinical Endocrinology, 39(4), 433-439.
  • Jones TH & Darne JF (1993) . Clinical Endocrinology, 38(2), 203-208.
  • Jones TH & Kennedy RL (1993) . Cytokine, 5(6), 531-538.
  • Jones TH, Kennedy RL, Justice SK & Price A (1993) . Acta Endocrinologica, 128(5), 405-410.
  • Jones TH, Brown BL, Cullen DR & Dobson PRM (1992) . Hormone Research, 37(3), 113-118.
  • Kennedy RL, Jones TH & Cuckle HS (1992) . Clinical Endocrinology, 37(6), 471-476.
  • Jones TH, Figueroa CD & Bhoola KD (1992) . Acta Endocrinologica, 127(6), 481-484.
  • Jones TH, Figueroa CD, Smith CM, Cullen DR & Bhoola KD (1992) . Journal of Endocrinology, 134(1), 149-NP.
  • Kennedy RL, Davies R, Macneil S, Jones TH & Lemoine NR (1992) . Clinical Science, 83(s27), 1P-2P.
  • Kennedy RL, Jones TH, Davies R, Justice SK & Lemoine NR (1992) . Journal of Endocrinology, 133(3), 477-482.
  • Rahman S, Bunning RAD, Dobson PRM, Evans DB, Chapman K, Jones TH, Brown BL & Russell RGG (1992) . Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1135(1), 97-102.
  • Jones TH, Figueroa CD, Smith CM & Bhoola KD (1992) Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.. Agents Actions Suppl, 38 ( Pt 2), 175-182.
  • Jones TH (1991) . Hormone Research, 35(2), 82-85.
  • Jones TH, Kennedy RL, Cullen DR & Smith CML (1991) . Clinical Science, 81(s25), 11P-12P.
  • Kennedy RL & Jones TH (1991) . Journal of Endocrinology, 129(2), 167-178.
  • JONES TH, JUSTICE S, PRICE A & CHAPMAN K (1991) . The Journal of Clinical Endocrinology & Metabolism, 73(1), 207-209.
  • Jones TH, Bergvall V & Bradshaw JPP (1990) . Postgraduate Medical Journal, 66(779), 747-750.
  • Jones TH, Brown BL & Dobson PRM (1990) . Acta Endocrinologica, 123(1), 37-42.
  • Jones TH, Figueroa CD, Smith C, Cullen DR & Bhoola KD (1990) . Journal of Endocrinology, 124(2), 327-NP.
  • Jones TH, Brown BL & Dobson PRM (1990) . Journal of Endocrinology, 127(1), 5-13.
  • (1989) . BMJ, 298(6674), 668-670.
  • Jones TH, Brown BL & Dobson PRM (1989) . Journal of Molecular Endocrinology, 2(1), 47-53.
  • Jones TH & Kennedy RL (1988) . BMJ, 297(6658), 1268-1268.
  • Kennedy RL, Jones TH & Shaukat HN (1988) . BMJ, 297(6648), 621-622.
  • Kennedy RL & Jones TH (1988) . BMJ, 296(6637), 1670-1671.
  • Jones TH, Brown BL & Dobson PRM (1988) . Journal of Endocrinology, 116(3), 367-371.
  • Jones TH, Kanis JA & Yates AJ (1985) . Journal of Neurology, Neurosurgery & Psychiatry, 48(4), 390-391.
  • Yates AJ, Jones TH, Mundy KI, Hague RV, Brown CB, Guilland-Cumming D & Kanis JA (1984) . BMJ, 289(6452), 1111-1112.
  • Austin CA, Cann PA, Jones TH & Holdsworth CD (1984) . The Lancet, 323(8382), 917-918.
  • Khera M, Torres LO, Grober ED, Morgentaler A, Miner M, Jones TH, Mills JN & Salonia A () . Sexual Medicine Reviews.
  • Zitzmann M, Rastrelli G, Murray RD, Edwards D, Reisman Y, Rao PM, Sahi A, Jones TH, Ferlin A, Armeni E , Corpas E et al () . Andrology.
  • Mumdzic E, Muraleedharan V, Kelly DM, Kapoor D & Jones TH () . Endocrine Abstracts.
  • Kelly D, Akhtar S, Muraleedharan V, Brooke J, McLaren D, Channer K & Jones TH () . Endocrine Abstracts.
  • Kelly D, Muraleedharan V, Akhtar S, Channer K & Jones TH () . Endocrine Abstracts, 1-1.
  • Jones H () . Clinical Interventions in Aging, Volume 3, 25-44.
  • Pugh PJ, Jones RD, Jones TH & Channer KS () . Endocrine, 19(2), 155-162.

Book chapters

  • Jones TH & Channer KS (2012) , Testosterone (pp. 235-250). Cambridge University Press
  • Channer KS & Jones TH (2012) , Testosterone (pp. 207-234). Cambridge University Press

Conference proceedings

  • Rao PM, Jones TH & Kelly D (2023) Testosterone improves symptom severity, quality of life (QOL), triglycerides and strength: A randomised placebo-controlled study in men with uncontrolled type-2 diabetes and hypogonadism: Stride study. DIABETIC MEDICINE, Vol. 40
  • Gul M, Luca B, Dimitropoulos K, Capogrosso P, Milenkovic U, Cocci A, Veeratterapillay R, Hatzichristodoulou G, Modgil V, Russo GI , Tharakan T et al (2021) What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review. EUROPEAN UROLOGY, Vol. 79 (pp S463-S464)
  • Malipatil NS, Yadegarfar G, Lunt M, Keevil B, Siddals K, Livingston M, Roberts S, Narayanan P, Rutter M, Gibson JM , Donn R et al (2019) . Endocrinology, Diabetes & Metabolism, Vol. 2(3)
  • Kelly DM, Harrison PS, Akhtar S & Jones TH (2014) Testosterone Increases Glucose Uptake and Glycolysis in HepG2 Human Liver Cells. ENDOCRINE REVIEWS, Vol. 35(3)
  • Bokhamada HK, Woodroofe MN, Jones TH, Small SH, Kay W & Dalton CF (2013) . Atherosclerosis, Vol. 231(2) (pp e6-e6)
  • Rao P, Brooke JC, Mclaren D, Walter DJ, Muraleedharan V & Jones TH (2013) Testosterone therapy improves HbA1c and other cardiovascular risk factors in hypogonadal men with poorly controlled diabetes: a retrospective analysis of five years of clinical practice. DIABETIC MEDICINE, Vol. 30 (pp 146-146)
  • Kelly DM, Sellers DJ, Woodroofe MN, Jones TH & Channer KS (2013) . Endocrine Research, Vol. 38(3) (pp 125-138)
  • Beaudet A, Gilmour L, Church N, Lloyd A, McLeod E & Jones TH (2010) . Journal of Men's Health, Vol. 7(3) (pp 289-289)
  • Muraleedharan V, Jones TH & Hassan HMJ (2010) Acute Visual Loss Due to PDE5 Inhibitor Induced Non Arteritic Anterior Ischaemic Optic Neuropathy in a Young Man with Hypogonadism and Erectile Dysfunction.. ENDOCRINE REVIEWS, Vol. 31(3)
  • Muraleedharan V, Ranjan N, Rolfe C & Jones TH (2010) The Effect of Testosterone Undecanoate on Cardiovascular Risk Factors in Men with Hypogonadism in Clinical Practice.. ENDOCRINE REVIEWS, Vol. 31(3)
  • Muraleedharan V, Marsh H & Jones TH (2010) Low Testosterone Level Is Associated with Significant Increase in All Cause and Cardiovascular Mortality in Men with Type 2 Diabetes.. ENDOCRINE REVIEWS, Vol. 31(3) (pp S863-S863)
  • Jones TH (2010) Hypogonadism and Type 2 Diabetes - An evidence based approach. INTERNATIONAL JOURNAL OF ANDROLOGY, Vol. 33 (pp 97-98)
  • Rigby E, Jones TH & Muraleedharan V (2010) Should Men with Isolated Secondary Hypogonadism with Low or Low Normal Gonadotrophins Have MRI Pituitary Scans? An Audit of 100 Patients.. ENDOCRINE REVIEWS, Vol. 31(3)
  • Jones TH (2009) HYPOGONADISM IN DIABETES. JOURNAL OF ANDROLOGY, Vol. 30 (pp 13-13)
  • Malkin CJ, Morris P, Jones TH & Channer KS (2009) Low serum testosterone and increased mortality in men with coronary disease. EUROPEAN HEART JOURNAL, Vol. 30 (pp 774-774)
  • Salim M, Aung M, Jones TH & Merza Z (2008) Blood pressure control in Type 2 diabetes patients (clinic and 24-hour ambulatory blood pressure monitor comparison). DIABETIC MEDICINE, Vol. 25
  • Stanworth RD, Kapoor D, Channer KS & Jones TH (2007) Statin use is associated with lower total testosterone levels but not bioavailable or free testosterone in men with Type 2 diabetes. DIABETIC MEDICINE, Vol. 24 (pp 69-69)
  • Stanworth RD, Kapoor D, Channer KS & Jones TH (2007) HDL cholesterol levels are positively associated with testosterone levels in men with Type 2 diabetes. DIABETIC MEDICINE, Vol. 24 (pp 79-79)
  • Smith AM, Sandher RK, Bennett RT, Jones TH, Jones RD, Cowen ME & Channer KS (2007) Characterisation of the vasodilatory action of 17 beta oestradiol in the human pulmonary circulation. EUROPEAN HEART JOURNAL, Vol. 28 (pp 57-57)
  • Hall J, Jones RD, Clarke S, Hopkinson DN, Cooper GJ, Locke TJ, Survana SK, Jones TH & Charmer KS (2006) The vasodilatory action of testosterone is independent of the endothelium, classic androgen receptor, aromatase activity, nitric oxide and dilator prostaglandins in isolated human pulmonary vessels. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 344A-345A)
  • Malkin CJ, Pugh PJ, West JN, Van Beek E, Jones TH & Channer KS (2006) Testosterone therapy in men with moderate severity heart failure: a double blind RCT. EUROPEAN HEART JOURNAL, Vol. 27 (pp 23-23)
  • Smith AM, Bennett RT, Jones TH, Cowen ME, Channer KS & Jones RD (2006) Characterisation of the vasodilatory action of testosterone in the human pulmonary circulation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 306A-307A)
  • Malkin CJ, Pugh PJ, West JN, van Beek E, Jones TH & Channer KS (2005) Testosterone therapy in men with heart failure: A double blind placebo controlled trial. HEART, Vol. 91 (pp A20-A21)
  • Smith AM, Bennett RT, Jones TH, Cowen ME, Channer KS & Jones RD (2005) Characterisation of the vasodilatory action of testosterone in the human pulmonary circulation. THORAX, Vol. 60 (pp II7-II7)
  • Hall J, Jones RD, Kong P, Jones TH, Peers C & Channer KS (2005) Testosterone inhibits extracellular calcium entry via voltage-gated calcium channels in A7r5 vascular smooth muscle cells at physiological concentrations. HEART, Vol. 91 (pp A43-A43)
  • Smith AM, Jones RD, Jones TH & Channer KS (2005) A comparison of the vasodilatory action of testosterone in isolated male and female human pulmonary arteries. EUROPEAN HEART JOURNAL, Vol. 26 (pp 610-610)
  • Scragg JL, Jones RD, Jones TH, Channer KS & Peers C (2004) . Journal of the American College of Cardiology, Vol. 43(5) (pp A494-A494)
  • Scragg JL, Jones RD, Jones TH, Channer KS & Peers C (2004) Testosterone inhibits calcium currents in A7R5 vascular smooth muscle cells, and in HEK293 cells stably expressing the α1C subunit of L type calcium channels and α1H T type calcium channels. HEART, Vol. 90 (pp A44-A44)
  • NETTLESHIP J (2003) . European Heart Journal, Vol. 24(5) (pp 435-435)
  • Pugh PJ, Malkin CJ, Morris PD, Nettleship J, Jones RD, Jones TH & Channer KS (2003) . Journal of the American College of Cardiology, Vol. 41(6) (pp 344-344)
  • MALKIN C (2003) . European Heart Journal, Vol. 24(5) (pp 709-709)
  • MALKIN C (2003) . European Heart Journal, Vol. 24(5) (pp 20-20)
  • JONES R (2003) . European Heart Journal, Vol. 24(5) (pp 342-342)
  • Pugh PJ, Malkin CJ, Morris PD, Asif S, Jones RD, Jones TH & Channer KS (2003) . Journal of the American College of Cardiology, Vol. 41(6) (pp 344-344)
  • Rowell KO, Jones RD, Pugh PJ, Jones TH & Channer KS (2003) Comparison of the vasodilatory action of testosterone in isolated human pulmonary and mesenteric arteries and veins. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 138 (pp U76-U76)
  • Rowell KO, Jones RD, Pugh PJ, Jones TH & Channer KS (2003) Testosterone is an efficacious vasodilator in isolated human pulmonary and mesenteric arteries and veins. HEART, Vol. 89 (pp A30-A30)
  • Jones RD, Roberts SA, Ruban LN, Pugh PJ, English KM, Jones TH & Channer KS (2003) Testosterone does not increase the intracellular concentration of cGMP in A7r5 aortic smooth muscle cells. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 138 (pp U75-U75)
  • Roberts SA, Gallagher O, Jones RD, English KM, Jones TH & Channer KS (2002) Quantification of lumen occlusion due to neointimal cell growth in cultured thoracic aortae from testicular feminized and control mice. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 137
  • Pugh PJ, Jones RD, Nettleship J, Jones TH & Channer KS (2002) Testosterone suppresses cytokine production in whole blood from men with heart failure. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 135
  • Nettleship JE, Jones RD, Pugh PJ, Jones TH & Channer KS (2002) Serum cytokine levels in male patients with stable coronary artery disease. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 137
  • Pugh PJ, West JN, Jones TH & Channer KS (2002) Testosterone therapy improves exercise duration and symptoms in men with chronic congestive heart failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 39(5) (pp 155A-155A)
  • Rowell KO, Gill S, Wagstaff J, Jones RD, Pugh PJ, Jones TH & Channer KS (2002) Assessment of the vasodilatory action of testosterone in isolated human pulmonary arteries and veins. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 137
  • Pugh PJ, Jones TH & Channer KS (2002) Acute haemodynamic effects of testosterone administration in men with heart failure. EUROPEAN HEART JOURNAL, Vol. 23 (pp 28-28)
  • Jones RD, Ruban LN, Pugh PJ, English KM, Jones TH & Channer KS (2002) Testosterone inhibits agonist-induced increases in intracellular calcium in rat aortic smooth muscle cells. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 135
  • Jones RD, Pugh PJ, English KM, Jones TH & Channer KS (2002) Isolated arteries from testicular feminised mice have maintained dilator responses to testosterone but reduced vascular reactivity to acetylcholine. BRITISH JOURNAL OF PHARMACOLOGY, Vol. 135
  • Pugh PJ, Jones RD, Nettleship J, Kerry K, Jones TH & Channer KS (2001) Testosterone suppresses tumour necrosis factor production in whole blood from men with heart failure. EUROPEAN HEART JOURNAL, Vol. 22 (pp 498-498)
  • English K, Steeds RP, Birchall AS, Jones TH & Channer KS (2000) Low dose transdermal testosterone therapy improves myocardial ischaemia and quality of life in men with chronic stable angina. EUROPEAN HEART JOURNAL, Vol. 21 (pp 364-364)
  • JONES TH, JUSTICE SK, KENNEDY RL & PRICE A (1992) KININS STIMULATE PHOSPHOINOSITIDE TURNOVER AND HORMONE-RELEASE FROM HUMAN PITUITARY-ADENOMAS - AN ASSOCIATION WITH IL-6 SECRETION. JOURNAL OF ENDOCRINOLOGY, Vol. 135 (pp P91-P91)
  • BHOOLA KD, CULLEN DR, FIGUEROA CD, JONES TH & SMITH CM (1990) COPRESENCE OF IMMUNOREACTIVE TISSUE KALLIKREIN AND PROLACTIN IN HUMAN ANTERIOR-PITUITARY ADENOMAS. JOURNAL OF PHYSIOLOGY-LONDON, Vol. 422 (pp P57-P57)
  • JONES TH, BROWN BL & DOBSON PRM (1987) BRADYKININ STIMULATES INOSITOL PHOSPHATE PRODUCTION AND PROLACTIN-RELEASE IN RAT ANTERIOR-PITUITARY-CELLS. JOURNAL OF ENDOCRINOLOGY, Vol. 112 (pp 155-155)
  • KANDLER RH, JONES TH, BEVAN BR, BROWN BL & CULLEN DR (1987) THE CONTROL OF PROLACTIN SECRETION BY GABA IN PATIENTS WITH PITUITARY-ADENOMAS. JOURNAL OF ENDOCRINOLOGY, Vol. 112 (pp 87-87)
  • JONES TH, BROWN BL & DOBSON PRM (1986) EVIDENCE THAT ANGIOTENSIN-II IS A PARACRINE AGENT MEDIATING GNRH STIMULATED PROLACTIN SECRETION. JOURNAL OF ENDOCRINOLOGY, Vol. 111 (pp 134-134)
  • Smith A () . Vascular Health and Risk Management, Vol. Volume 4 (pp 1459-1466)
Professional activities and memberships

International and National Committee Membership

President of the Androgen Society (International) 2021-2023

Vice President of Androgen Society 2019-2021

Treasurer of Androgen Society 2017-2019

Chair Academic Sub-committee Association of British Clinical Diabetologists and Committee Member 2014-2020

International and National Guideline and Society Committees

Guideline committee Member for European Association of Urology for Male Hypogonadism (2015-2019) followed by Sexual and Reproductive Health (2020-2024).

Guideline Committee Member British Society for Sexual Medicine Testosterone Therapy 2017 and 2023

International Consultation for Sexual Medicine 2019, 2024 (International Society for Sexual Medicine Committee Member 2022-2023.

Standardisation of Thresholds and Reporting of Testosterone of Male Hypogonadism in UK (Society for Endocrinology, UKNEQAS, Association of Clinical Biochemistry and Laboratory Medicine (ACB) and the International Federation of Clinical Biochemistry (IFCC).

Association of British Clinical Diabetologists (ABCD) Lead for Worldwide Audit of Testosterone in Diabetes 2020 - Present

Parliamentary Working Party for Men’s Health

NHS Diabetes Factsheets Committee (two) on (1) Erectile Dysfunction (2) Diabetes and Hypogonadism 2011

Chair Specialist Executive Committee for the Three Deaneries - Leicester, Nottingham, South Yorkshire for Diabetes and Endocrinology (2007-2010)

Training Programme Director for SpR’s in Diabetes and Endocrinology in South Yorkshire (1999-2010)

Society for Endocrinology Hypogonadism and Aging Statement 2012

Society for Endocrinology, Corporate Liaison Committee Member 2007-2010

Society for Endocrinology Convener  for Special Interest Group in Andrology 2010-2013

Editorial Boards

Associate Editor -      Therapeutic Advances in Endocrinology and Metabolism (2009-2015)

                                           Androgens: Clinical Research and Therapeutics (2019-2022)

Sub-section Editor  Journal of Men Health 2013 to present

Editorial Board: -       Clinical Endocrinology (2009-2012)

                                         Nature Scientific Reports (2014-2017)

                                         American Journal of Men’s Health (2011-2023)                             

                                          British Journal of Diabetes (2014-present)

                                         Androgens Clinical Research and Therapeutics (2019-present)     

             

Media

Testosterone 'could prevent heart and diabetes deaths' -

How many middle-aged men need HRT? -  

Hormone could treat heart failure -

EASD TV October 2023 through ABCD website 

ABCD audits prominent at recent EASD -

Endocrine Today òݸ Interviews

Link between testosterone and diabetes: Many questions remain -

Testosterone replacement may improve death rate in testosterone-deficient men with diabetes -

Testosterone therapy reduces CV events, death in men with hypogonadism -

TRAVERSE: Men using testosterone replacement do not have increased risk for CV events -

Testosterone therapy improves quality of life in men with hypogonadism, type 2 diabetes -

Testosterone therapy may benefit men with diabetes and obesity, but remains controversial -

Testosterone therapy may lower HbA1c for men with type 2 diabetes, hypogonadism -

Testosterone therapy does not slow progression to diabetes, increase odds for remission -